摘要 |
<p>The present invention relates to methods for treating or preventing a disorder of lipid metabolism, pain, diabetes, a vascular condition, demyelination or nonalcoholic fatty liver disease, comprising administering a compound having the formula (I) or a pharmaceutically acceptable salt, solvate, ester, prodrug or stereoisomer thereof, wherein: R<SUP>1</SUP> and R<SUP>2</SUP> are defined in Tables 1-6 herein, and R<SUB>3</SUB> is -phenyl, -4-chlorophenyl, -2-pyridyl, or -3-pyridyl.</p> |
申请人 |
SCHERING CORPORATION;ASLANIAN, ROBERT, G.;CHAN, TIN-YAU;HARRIS, JOEL, M.;MCKITTRICK, BRIAN, A.;NEUSTADT, BERNARD, R.;PALANI, ANANDAN;PRIESTLEY, TONY;SMITH, ELIZABETH, M.;STAMFORD, ANDREW, W.;VACCARO, HENRY, M.;XIAO, DONG |
发明人 |
ASLANIAN, ROBERT, G.;CHAN, TIN-YAU;HARRIS, JOEL, M.;MCKITTRICK, BRIAN, A.;NEUSTADT, BERNARD, R.;PALANI, ANANDAN;PRIESTLEY, TONY;SMITH, ELIZABETH, M.;STAMFORD, ANDREW, W.;VACCARO, HENRY, M.;XIAO, DONG |